Overview

Companies

Metrics

Purchase

Budget Metrics:

• Average per-patient clinical trial costs in the US
  • by therapeutic area
  • by development phase (Phase 1, Phase 2, Phase 3 and Phase 4)
• Percentage of clinical development budgets outsourced for US-based trials
  • by therapeutic area
  • by development phase (Phase 1, Phase 2, Phase 3 and Phase 4)
• Cost savings of clinical trials in India
  

Staffing Metrics:

• Trial-specific staffing for 71 clinical trials covering about 10 therapeutic areas
  • including trial size and location(s)
  • by development phase (Phase 1, Phase 2, Phase 3 and Phase 4)
  • by the following clinical development functions and roles
    • VPs and therapeutic area supervisors
    • trial managers
    • CRAs/monitors
    • data management
    • medical writing
    • biostatistics/bioanalytics
    • regulatory
    • clinical quality assurance
    • clinical trial supplies
    • CMC
    • contract management
    • drug safety
• Percentage of in-house and outsourced staff
  • by therapeutic area
  • by development phase (Phase 1, Phase 2, Phase 3 and Phase 4)
• Patients per CRA
  • by development phase (Phase 1, Phase 2, Phase 3 and Phase 4)
  • by company size (small, mid-sized and large sponsors)
    

Performance Metrics:

• Percentage of surveyed companies that track various performance measures for:
  • Cycle times and time-based trial milestones
  • Resource allocation-based metrics (budgets and staffing)
  • Efficiency and operations-based measures
• Surveyed companies' actual and target performance metrics for:
  • Cycle times and time-based trial milestones
  • Resource allocation-based metrics (budgets and staffing)
  • Efficiency and operations-based measures
• Surveyed companies' assessments of metrics that have power to affect organizational change for:
  • Cycle times and time-based trial milestones
  • Resource allocation-based metrics (budgets and staffing)
  • Efficiency and operations-based measures
    

Other Metrics:

• Factors impacting rising clinical development costs in the US (2006 vs. 2004)
• Average number of patients per trial
  • by therapeutic area
  • by development phase (Phase 1, Phase 2 and Phase 3)
• Percentages of trials consumed by various trial activities
• Marketing tactics' impact on patient recruitment
• Surveyed companies' rankings of opportunities for trial acceleration
• Surveyed companies' rankings of patient recruitment incentives
• Surveyed companies' rankings of investigator recruitment tools
• Surveyed companies' rankings of investigator incentives